Colinz Laboratories Stock Screener | Share Price & Fundamental Analysis
COLINZ
Pharmaceuticals
Screen Colinz Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹54.07
▼
-0.90 (-1.64%)
Market Cap
₹24.20 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.08
EPS (TTM)
₹1.97
Dividend Yield
-
Debt to Equity
0.07
52W High
₹84.48
52W Low
₹38.64
Operating Margin
7.00%
Profit Margin
16.67%
Revenue (TTM)
₹6.00
EBITDA
₹1.00
Net Income
₹1.00
Total Assets
₹12.00
Total Equity
₹10.00
Colinz Laboratories Share Price History - Stock Screener Chart
Screen COLINZ historical share price movements with interactive charts. Analyze price trends and patterns.
Colinz Laboratories Company Profile - Fundamental Screener
Screen Colinz Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for COLINZ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE923C01011
Colinz Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen COLINZ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Current Assets | 9 | 9 | 8 | 7 | 7 | 6 | 6 | 6 | 5 | 5 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 12 | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 9 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 6 |
| Share Capital | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 7 | 6 | 6 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
Screen COLINZ income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 7 | 7 | 7 | 7 | 6 | 8 | 8 | 8 | 8 | 8 | 8 |
| Expenses | 6 | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 7.00% | 8.00% | 8.00% | 9.00% | 8.00% | 5.00% | 4.00% | 5.00% | 5.00% | 5.00% | 6.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 1.80 | 1.97 | 1.93 | 1.82 | 0.74 | 0.45 | -0.01 | 0.34 | 0.65 | 0.40 | 0.21 | 0.21 |
Colinz Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen COLINZ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | 1 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Cash Flow | -2 | 1 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 |
Screen COLINZ shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.44% | 31.04% | 30.97% | 31.09% | 30.95% | 31.04% | 31.01% | 31.88% |
| Other Holding | 3.56% | 2.95% | 3.03% | 2.91% | 3.05% | 2.96% | 2.99% | 2.00% |
| Shareholder Count | 3,216 | 3,238 | 3,272 | 2,929 | 2,980 | 3,116 | 3,202 | 2,863 |
Colinz Laboratories Dividend Screener - Share Yield Analysis
Screen COLINZ dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Colinz Laboratories Index Membership - Market Screener Classification
Screen COLINZ by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Colinz Laboratories Market Events Screener - Corporate Actions
Screen COLINZ market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.86% | ||
| Annual General Meeting | NA | -8.26% | ||
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.94% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 12.74% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 13.57% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | -3.37% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 4.60% |
Colinz Laboratories Competitors Screener - Peer Comparison
Screen COLINZ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,177 | 40.80 | 54,729 | 9.71% | 10,980 | 55.31 |
| Divis Laboratories | 167,059 | 67.69 | 9,712 | 18.67% | 2,191 | 40.39 |
| Torrent Pharmaceuticals | 127,621 | 59.43 | 11,539 | 6.99% | 1,911 | 55.07 |
| Cipla | 120,913 | 22.30 | 28,410 | 7.12% | 5,291 | 42.59 |
| Dr Reddys Laboratories | 106,163 | 18.61 | 33,741 | 16.73% | 5,725 | 55.82 |
| Lupin | 96,517 | 21.96 | 22,910 | 13.74% | 3,306 | 62.97 |
| Zydus Life Science | 92,382 | 18.29 | 23,511 | 18.55% | 4,615 | 38.19 |
| Mankind Pharma | 87,142 | 49.02 | 12,744 | 20.90% | 2,007 | 26.69 |
| Aurobindo Pharma | 69,290 | 20.00 | 32,346 | 9.43% | 3,484 | 51.87 |
| Alkem Laboratories | 67,297 | 28.08 | 13,458 | 3.70% | 2,216 | 48.73 |
Colinz Laboratories Company Announcements - News Screener
Screen COLINZ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Submissions Of Disclosers Under Regulation 7(2) Of SEBI PIT Regulation 2015 | View |
| 2026-01-06 | Disclosure Under Regulation 29(2) Of SEBI SAST Regulations 2011 | View |
| 2026-01-06 | Regulation 10(6) Of SEBI (SAST) Regulation 29(2) | View |
| 2025-11-27 | REVISED Outcome Of The Board Meeting | View |
| 2025-11-27 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-11-27 | Outcome Of The Board Meeting | View |
| 2025-11-27 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-11-27 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-24 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-17 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-11 | Intimation Regarding Appointment Of Additional Director (Non-Executive Non-Independent Director.) | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of The Board Meeting | View |
| 2025-11-08 | Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015. | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Demise | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-03 | FIANACIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30-9-2025 | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-03 | Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |